טוען...
Clinical Impact of Renin‐Angiotensin System Blockade: Angiotensin‐Converting Enzyme Inhibitors vs. Angiotensin Receptor Antagonists
Clinical trials have proved that blockade of the renin‐angiotensin‐aldosterone system (RAAS) offers primary and secondary protection of the cardiovascular system, brain, and kidneys. Drugs that interrupt the RAAS do so by several diverse mechanisms but it remains to be fully proved whether these mec...
שמור ב:
| הוצא לאור ב: | J Clin Hypertens (Greenwich) |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Le Jacq Communications, Inc.
2007
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8101830/ https://ncbi.nlm.nih.gov/pubmed/12461316 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1524-6175.2002.01361.x |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|